Medical Device News Magazine

Widex-Developed Artificial Intelligence Promises to Revolutionize Hearing Aids

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Widex is the first hearing aid company to use AI to optimize hearing aid performance in real-time.

Widex notes having transformed the performance of a broad spectrum of consumer and industrial products, artificial intelligence (AI) is now set to revolutionize the quality of a product that the U.S. National Institutes of Health says half of the consumers aged 75 and over desperately need: hearing aids.

Bringing opportunity to fruition, Widex is the first hearing aid manufacturer to utilize real-time AI to create a better, more natural and personalized sound experience for hearing aid users. “By applying artificial intelligence, a hearing solution learns how users prefer various listening environments and gives them greater control over their hearing experience,” Widex Head of Audiology Lise Henningsen said. “By being the first to embrace AI, Widex benefits from years of continuous machine learning and hearing aid optimization that other hearing aid manufacturers have not yet developed. It is a key reason Widex is able to deliver its revolutionary natural sound.”

Powered by AI, Widex SoundSense Learn processes inputs from connected hearing aids throughout the world and shares anonymized data with a cloud-based AI system. The system then continuously learns how to further optimize hearing aid settings in different situations for specific wearers.

Widex SoundSense Learn presents users with A-B comparisons to begin understanding how a person wearing compatible Widex hearing aids prefers sound in an environment. SoundSense Learn manages three acoustic parameters — low, mid, and high frequencies — which can each be set to 13 different levels, resulting in more than 2,000 possible settings.

To A-B test each setting would require more than 2 million tests, but by using the power of machine-learning algorithms, Widex SoundSense Learn requires only about a dozen comparisons to calculate the optimal settings for the individual person. The SoundSense Learn algorithms also track the user’s individual adjustments and draw from other user settings stored in the cloud to more precisely tailor the hearing aids to one’s surroundings.

When applied, the settings create a personalized hearing experience based on context, content, and intent. Users can store the settings as programs in their smartphones and activate them throughout the day, such as when they’re at work, at the supermarket, or in their kitchen. Anonymized, the programs can also be stored in a secure, cloud-based system and help enhance the hearing experience of other users.

“Our studies show that hearing aid users have a significant preference for the personalized settings achieved through artificial intelligence and machine learning, and that 80 percent would recommend the function to others,” Henningsen added.

AI-equipped hearing aids such as the WIDEX MOMENT enhance our digital lives. “With AI, they are more like new lifestyle ‘hearables,’ which are key contributors to ubiquitous computing, just as virtual assistants and smart watches are,” Henningsen concluded.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”